Stemina Awarded $10 Million EPA Contract
News Jan 13, 2014
The contract will generate up to $10,637,000 in revenue for Stemina over the next 5 years. Under the contract, Stemina will screen drugs and chemicals, using its devTOX toxicology tests, for their potential to cause birth defects if a woman is exposed during pregnancy. “The EPA’s ToxCast initiative is the preeminent collection of toxicology information on a broad range of chemicals,” said Elizabeth Donley, CEO of Stemina. “As the only provider of an all human system designed to assess the potential for drugs and chemicals to cause birth defects, we are proud to have our devTOX tests included in this program. Our tests will provide valuable information about the impact that various classes of compounds can have on the developing human embryo.”
Stemina’s cell based tests arise from the strategic convergence of two cutting edge technologies: stem cells and metabolomics. Stemina has published on its devTOX assays in peer reviewed scientific journals since 2009 and is a recognized leader in human stem cell based toxicology.
ToxCast is a multi-year effort launched in 2007 at the EPA that uses automated chemical screening technologies (called "high-throughput screening assays") to expose living cells or isolated proteins to chemicals. The cells or proteins are then screened for changes in biological activity that may suggest potential toxic effects and eventually potential adverse health effects. These innovative methods have the potential to limit the number of required laboratory animal-based toxicity tests while quickly and efficiently screening large numbers of chemicals.
ToxCast has evaluated over 2,000 chemicals from a broad range of sources including: industrial and consumer products, food additives, and potentially "green" chemicals that could be safer alternatives to existing chemicals.
Innate Reaction of Hematopoietic Stem Cells to Severe InfectionsNews
Researchers at the University of Zurich have shown for the first time that hematopoietic stem cells detect infectious agents themselves and begin to divide, without signals from growth factors.READ MORE
Using Milk Protein to 3D-Imprint Muscle and Bone CellsNews
Researchers from the University of Canterbury are replicating a 3D imprint of cells onto films made of milk protein. The films then gradually degrade, leaving the grown tissue behind.READ MORE
Comments | 0 ADD COMMENT
EMBO Workshop: Integrating Systems Biology: From Networks to Mechanisms to Models
Apr 15 - Apr 17, 2018
EMBL Course: Transgenic Animals - Micromanipulation Techniques
Apr 10 - Apr 11, 2018
EMBO Practical Course: Extracellular Vesicles: From Biology to Biomedical Applications
Apr 09 - Apr 13, 2018
EMBL Course: Introduction to Metabolomics Analysis
Mar 20 - Mar 23, 2018